PTGX logo

Protagonist Therapeutics (PTGX) Net income

annual net income:

$275.19M+$354.14M(+448.54%)
December 31, 2024

Summary

  • As of today (June 22, 2025), PTGX annual net profit is $275.19 million, with the most recent change of +$354.14 million (+448.54%) on December 31, 2024.
  • During the last 3 years, PTGX annual net income has risen by +$400.74 million (+319.18%).
  • PTGX annual net income is now at all-time high.

Performance

PTGX Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

quarterly net income:

-$11.65M-$143.33M(-108.85%)
March 1, 2025

Summary

  • As of today (June 22, 2025), PTGX quarterly net profit is -$11.65 million, with the most recent change of -$143.33 million (-108.85%) on March 1, 2025.
  • Over the past year, PTGX quarterly net income has dropped by -$219.00 million (-105.62%).
  • PTGX quarterly net income is now -105.62% below its all-time high of $207.34 million, reached on March 31, 2024.

Performance

PTGX quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

TTM net income:

$56.19M-$219.00M(-79.58%)
March 1, 2025

Summary

  • As of today (June 22, 2025), PTGX TTM net profit is $56.19 million, with the most recent change of -$219.00 million (-79.58%) on March 1, 2025.
  • Over the past year, PTGX TTM net income has dropped by -$105.92 million (-65.34%).
  • PTGX TTM net income is now -79.58% below its all-time high of $275.19 million, reached on December 31, 2024.

Performance

PTGX TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

PTGX Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+448.5%-105.6%-65.3%
3 y3 years+319.2%+44.3%+145.9%
5 y5 years+456.5%+42.0%+167.6%

PTGX Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+316.0%-105.6%+71.6%-79.6%+140.0%
5 y5-yearat high+316.0%-105.6%+71.6%-79.6%+140.0%
alltimeall timeat high+316.0%-105.6%+71.6%-79.6%+140.0%

PTGX Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$11.65M(-108.9%)
$56.19M(-79.6%)
Dec 2024
$275.19M(-448.5%)
$131.67M(-496.5%)
$275.19M(+61.1%)
Sep 2024
-
-$33.21M(+8.5%)
$170.85M(+0.5%)
Jun 2024
-
-$30.62M(-114.8%)
$169.95M(+4.8%)
Mar 2024
-
$207.34M(+658.5%)
$162.11M(-305.3%)
Dec 2023
-$78.95M(-38.0%)
$27.34M(-180.1%)
-$78.95M(-43.8%)
Sep 2023
-
-$34.10M(-11.3%)
-$140.48M(+2.1%)
Jun 2023
-
-$38.46M(+14.0%)
-$137.61M(-1.8%)
Mar 2023
-
-$33.73M(-1.4%)
-$140.19M(+10.0%)
Dec 2022
-$127.39M(+1.5%)
-$34.19M(+9.5%)
-$127.39M(-2.1%)
Sep 2022
-
-$31.23M(-23.9%)
-$130.11M(-1.9%)
Jun 2022
-
-$41.04M(+96.1%)
-$132.68M(+8.3%)
Mar 2022
-
-$20.93M(-43.3%)
-$122.48M(-2.4%)
Dec 2021
-$125.55M(+89.8%)
-$36.91M(+9.2%)
-$125.55M(+16.8%)
Sep 2021
-
-$33.80M(+9.6%)
-$107.53M(+32.0%)
Jun 2021
-
-$30.84M(+28.5%)
-$81.49M(+16.3%)
Mar 2021
-
-$24.00M(+27.1%)
-$70.07M(+5.9%)
Dec 2020
-$66.15M(-14.3%)
-$18.89M(+143.3%)
-$66.15M(+2.1%)
Sep 2020
-
-$7.76M(-60.0%)
-$64.77M(-11.8%)
Jun 2020
-
-$19.42M(-3.3%)
-$73.41M(-11.7%)
Mar 2020
-
-$20.08M(+14.7%)
-$83.16M(+7.7%)
DateAnnualQuarterlyTTM
Dec 2019
-$77.19M(+98.3%)
-$17.50M(+6.7%)
-$77.19M(+4.9%)
Sep 2019
-
-$16.41M(-43.8%)
-$73.55M(+11.6%)
Jun 2019
-
-$29.17M(+106.9%)
-$65.88M(+45.2%)
Mar 2019
-
-$14.10M(+1.7%)
-$45.37M(+16.6%)
Dec 2018
-$38.92M(+5.3%)
-$13.87M(+58.7%)
-$38.92M(+38.5%)
Sep 2018
-
-$8.73M(+0.8%)
-$28.11M(+16.2%)
Jun 2018
-
-$8.66M(+13.1%)
-$24.20M(-20.7%)
Mar 2018
-
-$7.66M(+151.0%)
-$30.52M(-17.4%)
Dec 2017
-$36.96M(-0.6%)
-$3.05M(-36.7%)
-$36.96M(-18.2%)
Sep 2017
-
-$4.83M(-67.8%)
-$45.15M(-4.8%)
Jun 2017
-
-$14.98M(+6.2%)
-$47.41M(+19.9%)
Mar 2017
-
-$14.10M(+25.4%)
-$39.53M(+6.3%)
Dec 2016
-$37.18M(+150.2%)
-$11.25M(+58.8%)
-$37.18M(+18.3%)
Sep 2016
-
-$7.08M(-0.2%)
-$31.42M(+13.1%)
Jun 2016
-
-$7.10M(-39.6%)
-$27.79M(+16.2%)
Mar 2016
-
-$11.75M(+113.9%)
-$23.91M(+60.9%)
Dec 2015
-$14.86M(+34.2%)
-$5.49M(+59.3%)
-$14.86M(+58.7%)
Sep 2015
-
-$3.45M(+7.1%)
-$9.37M(+58.3%)
Jun 2015
-
-$3.22M(+19.4%)
-$5.92M(+119.4%)
Mar 2015
-
-$2.70M
-$2.70M
Dec 2014
-$11.07M
-
-

FAQ

  • What is Protagonist Therapeutics annual net profit?
  • What is the all time high annual net income for Protagonist Therapeutics?
  • What is Protagonist Therapeutics annual net income year-on-year change?
  • What is Protagonist Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Protagonist Therapeutics?
  • What is Protagonist Therapeutics quarterly net income year-on-year change?
  • What is Protagonist Therapeutics TTM net profit?
  • What is the all time high TTM net income for Protagonist Therapeutics?
  • What is Protagonist Therapeutics TTM net income year-on-year change?

What is Protagonist Therapeutics annual net profit?

The current annual net income of PTGX is $275.19M

What is the all time high annual net income for Protagonist Therapeutics?

Protagonist Therapeutics all-time high annual net profit is $275.19M

What is Protagonist Therapeutics annual net income year-on-year change?

Over the past year, PTGX annual net profit has changed by +$354.14M (+448.54%)

What is Protagonist Therapeutics quarterly net profit?

The current quarterly net income of PTGX is -$11.65M

What is the all time high quarterly net income for Protagonist Therapeutics?

Protagonist Therapeutics all-time high quarterly net profit is $207.34M

What is Protagonist Therapeutics quarterly net income year-on-year change?

Over the past year, PTGX quarterly net profit has changed by -$219.00M (-105.62%)

What is Protagonist Therapeutics TTM net profit?

The current TTM net income of PTGX is $56.19M

What is the all time high TTM net income for Protagonist Therapeutics?

Protagonist Therapeutics all-time high TTM net profit is $275.19M

What is Protagonist Therapeutics TTM net income year-on-year change?

Over the past year, PTGX TTM net profit has changed by -$105.92M (-65.34%)
On this page